文献速递流行病学与生物统计临床试验与 GCP

静息或运动心电图筛查心血管疾病风险:美国预防服务工作组证据报告与系统综述

Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
PubMed 文献 · JAMA · 2018-01-01

本系统综述旨在为美国预防服务工作组提供证据,评估心电图筛查无症状成人心血管疾病风险的效果。队列研究显示在传统危险因素基础上加做心电图可小幅改善判别与风险重分类,但证据存在局限性,危害频率不确定。

要点

  • 运动心电图筛查未显著改善糖尿病患者心血管结局(HR 1.00和0.85)。
  • 静息心电图加入传统危险因素可小幅改善判别与风险重分类。
  • 筛查危害频率不确定,证据质量有限。

核心结论

  • 运动心电图筛查RCT未显示健康结局改善,尽管聚焦糖尿病高危人群。
  • 静息心电图加入传统危险因素可准确重分类个体,但证据多局限。
  • 筛查危害频率不确定。

研究设计与样本

  • 检索MEDLINE、Cochrane图书馆和试验注册库至2017年5月,文献监测至2018年4月4日。
  • 纳入比较心电图加传统危险因素与单独传统危险因素的风险评估研究。

主要发现

  • 2项RCT(n=1151)比较运动心电图筛查与不筛查,在50-75岁糖尿病患者中主要心血管复合结局无显著改善(HR 1.00 [95% CI, 0.59-1.71]和0.85 [95% CI, 0.39-1.84])。
  • 无RCT评估静息心电图筛查。
  • 5项队列研究(n=9582)显示运动心电图加传统危险因素使判别力小幅改善(AUC或C统计量绝对改善0.02-0.03,3项研究报告)。
  • 总净重分类改善范围从3.6%(2.7%事件;0.6%非事件)到30%(17%事件;19%非事件),基于Framingham风险评分或汇总队列方程基础模型。

临床怎么用

  • 不推荐使用运动或静息心电图筛查无症状成人心血管疾病风险。
  • 传统危险因素评估仍是无症状成人风险分层的基础。

局限性

  • 证据受不精确性、质量、显著异质性和风险阈值使用不一致限制。
  • 无症状人群筛查潜在危害(如后续血管造影或血运重建)证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cardiovascular disease (CVD) is the leading cause of death in the United States. OBJECTIVE: To review the evidence on screening asymptomatic adults for CVD risk using electrocardiography (ECG) to inform the US Preventive Services Task Force. DATA SOURCES: MEDLINE, Cochrane Library, and trial registries through May 2017; references; experts; literature surveillance through April 4, 2018. STUDY SELECTION: English-language randomized clinical trials (RCTs); prospective cohort studies reporting reclassification, calibration, or discrimination that compared risk assessment using ECG plus traditional risk factors vs traditional risk factors alone. For harms, additional study designs were eligible. Studies of persons with symptoms or a CVD diagnosis were excluded. DATA EXTRACTION AND SYNTHESIS: Dual review of abstracts, full-text articles, and study quality; qualitative synthesis of findings. MAIN OUTCOMES AND MEASURES: Mortality, cardiovascular events, reclassification, calibration, discrimination, and harms. RESULTS: Sixteen studies were included (N = 77 140). Two RCTs (n = 1151) found no significant improvement for screening with exercise ECG (vs no screening) in adults aged 50 to 75 years with diabetes for the primary cardiovascular composite outcomes (hazard ratios, 1.00 [95% CI, 0.59-1.71] and 0.85 [95% CI, 0.39-1.84] for each study). No RCTs evaluated screening with resting ECG. Evidence from 5 cohort studies (n = 9582) showed that adding exercise ECG to traditional risk factors such as age, sex, current smoking, diabetes, total cholesterol level, and high-density lipoprotein cholesterol level produced small improvements in discrimination (absolute improvements in area under the curve [AUC] or C statistics, 0.02-0.03, reported by 3 studies); whether calibration or appropriate risk classification improves is uncertain. Evidence from 9 cohort studies (n = 66 407) showed that adding resting ECG to traditional risk factors produced small improvements in discrimination (absolute improvement in AUC or C statistics, 0.001-0.05) and appropriate risk classification for prediction of multiple cardiovascular outcomes, although evidence was limited by imprecision, quality, considerable heterogeneity, and inconsistent use of risk thresholds used for clinical decision making. Total net reclassification improvements ranged from 3.6% (2.7% event; 0.6% nonevent) to 30% (17% event; 19% nonevent) for studies using the Framingham Risk Score or Pooled Cohort Equations base models. Evidence on potential harms (eg, from subsequent angiography or revascularization) in asymptomatic persons was limited. CONCLUSIONS AND RELEVANCE: RCTs of screening with exercise ECG found no improvement in health outcomes, despite focusing on higher-risk populations with diabetes. The addition of resting ECG to traditional risk factors accurately reclassified persons, but evidence for this finding had many limitations. The frequency of harms from screening is uncertain.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Jonas DE, Reddy S, Middleton JC, et al. Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018. PMID: 29896633. doi:10.1001/jama.2018.6897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。